NPI: 1902051816 · SILOAM SPRINGS, AR 72761 · General Acute Care Hospital · NPI assigned 11/19/2008
Authorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
| Authorized Official | LALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL) |
| NPI Enumeration Date | 11/19/2008 |
Other providers sharing the same authorized official: LALOR, PAULA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 20,783 | $579K |
| 2019 | 22,366 | $629K |
| 2020 | 19,557 | $429K |
| 2021 | 32,338 | $691K |
| 2022 | 44,685 | $1.03M |
| 2023 | 50,467 | $1.01M |
| 2024 | 38,370 | $627K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 10,742 | 9,707 | $1.26M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 5,532 | 4,751 | $643K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2,729 | 2,237 | $352K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 9,524 | 8,421 | $304K |
| 70450 | Computed tomography, head or brain; without contrast material | 2,700 | 2,248 | $244K |
| 80053 | Comprehensive metabolic panel | 15,218 | 12,291 | $228K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 9,820 | 8,577 | $211K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 17,253 | 13,296 | $118K |
| 80048 | Basic metabolic panel (calcium, ionized) | 6,489 | 5,005 | $81K |
| 87430 | 6,400 | 5,817 | $80K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2,397 | 1,863 | $72K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 7,020 | 5,100 | $69K |
| 59025 | Fetal non-stress test | 482 | 304 | $68K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2,308 | 680 | $64K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 977 | 857 | $63K |
| 80306 | 3,975 | 2,997 | $59K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 891 | 704 | $53K |
| 81001 | 14,957 | 11,869 | $50K | |
| 71045 | Radiologic examination, chest; single view | 6,316 | 5,224 | $48K |
| 83880 | 1,360 | 1,087 | $46K | |
| 81025 | 5,947 | 4,880 | $44K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 384 | 315 | $43K |
| 84484 | 5,590 | 3,797 | $43K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2,993 | 2,424 | $37K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 543 | 475 | $36K |
| 71046 | Radiologic examination, chest; 2 views | 1,980 | 1,699 | $34K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 495 | 392 | $32K |
| 83690 | 5,047 | 4,080 | $32K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,592 | 1,124 | $30K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 3,951 | 2,985 | $30K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1,189 | 955 | $28K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 5,148 | 3,909 | $26K |
| 85027 | 5,236 | 4,285 | $25K | |
| 87081 | 2,657 | 2,401 | $24K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 473 | 413 | $24K |
| 36415 | Collection of venous blood by venipuncture | 2,089 | 1,432 | $22K |
| 82077 | 1,371 | 1,034 | $20K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 1,455 | 1,002 | $20K |
| 87807 | 1,562 | 1,421 | $18K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1,885 | 1,429 | $17K |
| 73630 | 729 | 608 | $16K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1,910 | 1,641 | $15K |
| 82962 | 3,246 | 1,539 | $15K | |
| 86901 | 984 | 706 | $14K | |
| 87040 | 1,691 | 792 | $14K | |
| 73610 | 780 | 662 | $14K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 914 | 625 | $13K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 4,674 | 3,755 | $12K |
| 73130 | 452 | 392 | $10K | |
| 83605 | 1,185 | 841 | $10K | |
| 80061 | Lipid panel | 1,664 | 1,463 | $10K |
| 80143 | 527 | 403 | $9K | |
| 80179 | 540 | 412 | $8K | |
| 73562 | 289 | 246 | $8K | |
| 73110 | 371 | 313 | $8K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,542 | 1,321 | $8K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 341 | 225 | $7K |
| 83735 | 1,533 | 1,167 | $7K | |
| 93970 | 328 | 244 | $7K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 168 | 138 | $7K |
| 73030 | 349 | 276 | $7K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 169 | 139 | $6K |
| 86850 | 645 | 466 | $6K | |
| 85610 | 2,311 | 1,690 | $5K | |
| 87088 | 645 | 515 | $5K | |
| 90715 | 404 | 307 | $5K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 15 | 12 | $3K |
| 87077 | 371 | 284 | $3K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 490 | 381 | $3K |
| 85730 | 736 | 606 | $3K | |
| 71020 | 191 | 181 | $3K | |
| 97161 | 105 | 80 | $3K | |
| 96376 | 81 | 49 | $2K | |
| 43235 | 21 | 12 | $2K | |
| 74018 | 111 | 96 | $2K | |
| 86900 | 813 | 580 | $2K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 580 | 487 | $2K |
| 71010 | 297 | 267 | $2K | |
| 87186 | 272 | 216 | $1K | |
| 86140 | 230 | 183 | $1K | |
| J0690 | Injection, cefazolin sodium, 500 mg | 1,458 | 941 | $1K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 1,775 | 1,367 | $1K |
| 85379 | 125 | 107 | $1K | |
| 84702 | 138 | 104 | $984.37 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,920 | 1,518 | $977.70 |
| 73502 | 62 | 49 | $876.77 | |
| 97162 | 17 | 12 | $741.60 | |
| 82150 | 102 | 83 | $725.21 | |
| 80076 | 50 | 39 | $690.06 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 2,047 | 1,558 | $666.35 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 20 | 12 | $542.43 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 1,384 | 1,043 | $519.87 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 934 | 702 | $453.76 |
| 73140 | 12 | 12 | $386.51 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 81 | 61 | $366.02 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 245 | 206 | $352.07 |
| J2704 | Injection, propofol, 10 mg | 2,103 | 1,564 | $319.22 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 34 | 27 | $284.39 |
| 73090 | 14 | 12 | $282.39 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 330 | 263 | $247.85 |
| 74000 | 15 | 14 | $240.00 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 1,102 | 771 | $229.36 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 129 | 99 | $192.26 |
| J2060 | Injection, lorazepam, 2 mg | 206 | 165 | $190.20 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 253 | 200 | $172.67 |
| 73560 | 17 | 12 | $166.27 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 17 | 13 | $141.28 |
| 82803 | 16 | 13 | $110.52 | |
| 87070 | 14 | 12 | $104.21 | |
| 94760 | 21 | 13 | $56.00 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 14 | 12 | $54.15 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 119 | 79 | $43.51 |
| 84439 | 12 | 12 | $38.64 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 83 | 67 | $30.41 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 87 | 68 | $27.85 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 899 | 788 | $26.77 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 33 | 25 | $20.76 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 36 | 26 | $15.66 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 42 | 37 | $12.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 50 | 34 | $4.50 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 64 | 40 | $1.86 |
| J7030 | Infusion, normal saline solution , 1000 cc | 445 | 311 | $0.00 |
| 97116 | 26 | 14 | $0.00 | |
| C9113 | Injection, pantoprazole sodium, per vial | 66 | 54 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 21 | 12 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 129 | 96 | $0.00 |
| J0687 | Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg | 39 | 17 | $0.00 |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 229 | 154 | $0.00 |
| G0378 | Hospital observation service, per hour | 71 | 50 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 34 | 27 | $0.00 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 14 | 13 | $0.00 |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 13 | 12 | $0.00 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 18 | 13 | $0.00 |